Table 1 Clinical characteristics of the COVID-19 patients in this study

Age, n(%)

6.89E-14

 < 60

25(39.1)

211(84.4)

236(75.2)

 ≥ 60

39(60.9)

39(15.6)

78(24.8)

 Median(IQR)

62.0(56.0–66.5)

40.0(32.0–55.0)

45.0(33.0–59.3)

5.11E-15^a

Gender, n(%)

0.002

 Male

42(65.6)

111(44.4)

153(48.7)

 Female

22(34.4)

139(55.6)

161(51.3)

Comorbidities,n(%)^b

 None

23(37.7)

186(80.5)

209(71.6)

6.00E-05^c

 Hypertension

23(37.7)

18(7.8)

41(14.0)

0.002^c

 Diabetes

15(24.6)

13(5.6)

28(9.6)

0.003^c

 Cardiovascular diseases

13(21.3)

5(2.2)

18(6.2)

0.023^c

 Liver disease

2(3.3)

5(2.2)

7(2.4)

0.792^c

 Lung disease

4(6.6)

5(2.2)

9(3.1)

0.348^c

 Chronic renal diseases

6(9.8)

1(0.4)

7(2.4)

0.159^c

 Cancers

1(1.6)

2(0.9)

3(1.0)

0.685^c